Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
- Outpatient
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
License/Certification/Accreditation
- Drug Enforcement Agency (DEA)
- State department of health
- SAMHSA certification for opioid treatment program (OTP)
- State Substance use treatment agency
Assessment/Pre-treatment
- Screening for mental disorders
- Screening for tobacco use
- Comprehensive substance use assessment
- Screening for substance use
- Outreach to persons in the community
- Comprehensive mental health assessment
- Interim services for clients
- Complete medical history/physical exam
Facility Operation (e.g., Private, Public)
- Private for-profit organization
Type of Care
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Pharmacotherapies
- Naltrexone (extended-release, injectable)
- Medication for mental disorders
- Buprenorphine without naloxone
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Disulfiram
- Naltrexone (oral)
Opioid Medications used in Treatment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
Transitional Services
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
Facility Vaping Policy
- Vaping permitted without restriction
Recovery Support Services
- Assistance with obtaining social services
- Mentoring/peer support
Testing
- STD testing
- Breathalyzer or blood alcohol testing
- HIV testing
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
Treatment Approaches
- Telemedicine/telehealth therapy
- Trauma-related counseling
- Substance use disorder counseling
- Cognitive behavioral therapy
- Motivational interviewing
- Relapse prevention
Payment/Insurance/Funding Accepted
- Medicaid
- SAMHSA funding/block grants
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Federal, or any government funding for substance use treatment programs
- Medicare
Ancillary Services
- Mental health services
- Integrated primary care services
Facility Smoking Policy
- Smoking permitted without restriction
Special Programs/Groups Offered
- Pregnant/postpartum women
Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder
Education and Counseling Services
- Substance use disorder education
- Individual counseling
- Family counseling
- Group counseling
- Smoking/vaping/tobacco cessation counseling
External Source of Medications Used for Alcohol Use Disorder Treatment
- Other contracted prescribing entity
Age Groups Accepted
Gender Accepted
Type of Opioid Treatment
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
Location
2925 East Colfax Avenue, Denver, CO 80206
Phone: (866) 453-5835
Website: http://www.magnoliamed.com
← All programs in Denver
5250 Leetsdale Drive, Ste. 220, Denver, CO
9725 East Hampden Avenue, Denver, CO
7555 East Hampden Avenue, Denver, CO
3660-3670 West Princeton Circle, Denver, CO
3680 West Princeton Circle, Denver, CO
3702-3712 West Princeton Circle, Denver, CO